Home Hangzhou DAC Biotech Signs Cross-Border ADC BD Deal with Whitehawk Therapeutics

Hangzhou DAC Biotech Signs Cross-Border ADC BD Deal with Whitehawk Therapeutics

May 22, 2026 13:15 CST Updated May 25, 15:35
WuXi Biologics

Contract Research, Development and Manufacturing Organization (CRDMO) Service Provider